Forty bottle-fed babies, 4–12 weeks old, with clinical gastro-oesophageal reflux were studied. Continuous 24 h oesophageal pH monitoring in a prone position demonstrated a gastro-oesophageal reflux with all of the following parameters: reflux index, duration of the longest reflux episode, number of reflux episodes in 24 h, number of reflux episodes >5 min in 24 h. Positional therapy (prone-antitrendelenburg position), applied to all infants, resulted in a normalization of these parameters in ten of them. The remaining 30 infants were treated with milk-thickening agents, as recommended by Carre. Nearly all (N=25) showed an important clinical improvement. A third pH monitoring was performed after 10–14 days of treatment. In six infants the results were completely within normal ranges. In 24 infants a decrease in the number of reflux episodes was demonstrated, with a comparable reflux index and number of long lasting reflux episodes. The duration of the longest reflux episode however increased significantly (P<0.001). Drugs (domperidone, Gaviscon) added to the milk-thickening agents in these 24 children, led to normalization of pH tracings. Clinical symptoms were less severe or disappeared in all infants but one. We conclude that if positional therapy (prone-antitrendelenburg) does not correct gastro-oesophageal reflux in infants, pharmacological treatment should be applied. Milk-thickening agents alone can be effective in individual cases but should be prescribed with care as they can lead to more occult gastro-oesophageal reflux with episodes of longer duration, increasing the risk of oesophagitis or respiratory distress.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Carre IJ (1985) Management of gastroesophageal reflux. Arch Dis Child 60:71–75
DeLoore I, Van Ravenstijn H, Amerijckx L (1979) Domperidone drops in the symptomatic treatment of chronic pediatric vomiting and regurgitation: a comparison with metoclopramide. Postrgrad Med J 55:40–42
Deprettere AR, Van Acker KJ, Du Caju MVL (1987) Increased serum prolactin but normal TSH during prolonged domperidone treatment in children. Eur J Pediatr 146:189–191
Herbst JJ (1981) Gastroesophageal reflux. J Pediatr 6:859–870
Hewitt GJ, Benham ES (1976) A complication of Gaviscon in a neonate — The Gavisconoma. Aust Pediatr J 15:263–265
Hillemeier AC, Grill BB, Mc Callum R, Gryborsky J (1983) Esophageal and gastric abnormalities in gastroesophageal reflux during infancy. Gastroenterology 84:741–746
Jewett TC, Siegel M (1984) Hiatal hernia and gastroesophageal reflux. J Pediatr Gastroenterol Nutr 3:340–345
Keipert JA (1979) The mode of action and complications of infant Gaviscon. Aust Pediatr J 15:263–65
McHardy G (1978) A multicentric randomized clinical trial of Gaviscon in reflux esophagitis. South Med J 71:16
Meyers WF, Herbst JJ (1982) Effectiveness of positioning therapy for gastroesophageal reflux. Pediatrics 69:768–762
Newman LJ, Berezin S, San Filippo JA, Halatta M, Medow MS, Schwarz SM (1985) A new ambulatory system for extended esophageal pH monitoring. J Pediatr Gastroenterol Nutr 4:707–710
Orenstein SR, Whitington PF (1983) Positioning for prevention of infant gastroesophageal reflux. J Pediatr 103:534–537
Reid M (1977) Dystonic reactions to metoclopramide (Maxolon). Ulster Med J 46:38–40
Stanciu C, Bennett JR (1974) Esophageal acid clearing: one factor in the production of reflux esophagitis. Gut 15:852–857
Vandenplas Y, Sacre L (1985) Seventeen hour continuous esophageal pH monitoring in the newborn: evaluation of the influence of position in asymptomatic and symptomatic babies. J Pediatr Gastroenterol Nutr 4:356–361
Vandenplas Y, Sacre L (1986) Influence of xanthines on gastroesophageal reflux in infants at risk for SIDS. Pediatrics 77:807–810
Vandenplas Y, Sacre L (1987) Gastroesophageal reflux incidence in 285 asymptomatic infants (0–15 months old). J Pediatr Gastroenterol Nutr 6:220–224
Weihrach TR (1985) Gastroesophageal reflux—pathogenesis and clinical implications. Eur J Pediatr 144:215–218
About this article
Cite this article
Vandenplas, Y., Sacré-Smits, L. Gastro-oesophageal reflux in infants. Eur J Pediatr 146, 504–507 (1987). https://doi.org/10.1007/BF00441604
- Gastro-oesophageal reflux
- Positional therapy
- Milk-thickening agent